• Mi Re-Unir
    Búsqueda Avanzada
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Ver ítem 
    •   Inicio
    • RESULTADOS DE INVESTIGACIÓN
    • Artículos Científicos WOS y SCOPUS
    • Ver ítem
    •   Inicio
    • RESULTADOS DE INVESTIGACIÓN
    • Artículos Científicos WOS y SCOPUS
    • Ver ítem

    Hepatitis delta in patients with resolved hepatitis B virus infection

    Autor: 
    Aguilera, Antonio
    ;
    Rodríguez-Calviño, Javier
    ;
    Mendoza, Carmen de
    ;
    Soriano, Vicente
    Fecha: 
    09/2018
    Palabra clave: 
    hepatitis B; hepatitis C; hepatitis delta; HIV; occult hepatitis; JCR; Scopus
    Revista / editorial: 
    European Journal of Gastroenterology & Hepatology
    Tipo de Ítem: 
    Articulo Revista Indexada
    URI: 
    https://reunir.unir.net/handle/123456789/7677
    DOI: 
    https://doi.org/10.1097/MEG.0000000000001187
    Resumen:
    Background The hepatitis delta virus (HDV) causes the most aggressive form of chronic viral hepatitis. As HDV replication requires hepatitis B virus (HBV), HDV screening is limited to HBsAg+ carriers. To date, individuals with HDV-antibodies and markers of resolved hepatitis B are considered cured. However, a subset shows elevated liver enzymes and hepatic fibrosis. Could they represent HBsAg-seronegative occult HDV infections? Methods We tested for HDV-antibodies 406 individuals with markers of past HBV exposure. Results Overall, 20 (4.9%) were reactive for HDV-antibodies. All were negative for serum HDV-RNA, including four with elevated liver enzymes. Conclusion These results support the current policy of screening for hepatitis delta only in HBsAg+ individuals.
    Mostrar el registro completo del ítem
    Este ítem aparece en la(s) siguiente(s) colección(es)
    • Artículos Científicos WOS y SCOPUS

    Estadísticas de uso

    Año
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    2025
    Vistas
    0
    0
    0
    0
    0
    0
    0
    109
    57
    34
    51
    52
    94
    36
    Descargas
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0

    Ítems relacionados

    Mostrando ítems relacionados por Título, autor o materia.

    • The unexpected high prevalence of HBV subgenotype D4 in patients with chronic hepatitis B in Galicia, a northwestern Spanish region, reflects strong links with Latin America 

      Trastoy, Rocío; González-Alba, José María; Soriano, Vicente ; Rodríguez-Calviño, José Javier; de Mendoza, Carmen; Costa, José Javier; Cea, María; Barbeito, Gema; Corral, Octavio Jorge ; Gómez-Gallego, Felix ; Pérez del Molino, María Luisa; Carlos Galán, Juan; Aguilera, Antonio (Journal of Clinical Virology, 2022)
      Background: Hepatitis B virus (HBV) comprises 9 genotypes and multiple subgenotypes that depict differences in geographic distribution, clinical outcome and response to antiviral therapy. However, the molecular epidemiology ...
    • Prevalence and incidence of hepatitis delta in patients with chronic hepatitis B in Spain 

      Aguilera, Antonio; Trastoy, Rocío; Rodríguez-Calviño, Javier; Manso, Tamara; Mendoza, Carmen de; Soriano, Vicente (European Journal of Gastroenterology & Hepatology, 09/2018)
      Background Hepatitis delta virus (HDV) is a defective agent that only replicates in the presence of the hepatitis B virus. Accordingly, HDV acquisition may occur as superinfection of HBsAg+ carriers or following acute dual ...
    • Susceptibility to hepatitis B virus infection in adults living in Spain 

      Soriano, Vicente; Aguilera, Antonio; Benito, Rafael; Gonzalez-Diez, Rocio; Miro, Elisenda; Liendo, Paloma; Rodriguez-Diaz, Juan Carlos; Cabezas, Teresa; Richart, Alberto; Ramos, José Manuel; Barea, Luisa; Alvarez, Carmen; Treviño, Ana; Gómez-Gallego, Felix; Corral, Octavio Jorge; de Mendoza, Carmen (Liver International, 2023)
      BackgroundA protective hepatitis B virus (HBV) vaccine has been available for four decades. Universal HBV vaccination of infants is recommended by the WHO since the 1990s. Furthermore, HBV immunization is advised for all ...

    Mi cuenta

    AccederRegistrar

    ¿necesitas ayuda?

    Manual de UsuarioContacto: reunir@unir.net

    Listar

    todo Re-UnirComunidades y coleccionesPor fecha de publicaciónAutoresTítulosPalabras claveTipo documentoTipo de accesoEsta colecciónPor fecha de publicaciónAutoresTítulosPalabras claveTipo documentoTipo de acceso






    Aviso Legal Política de Privacidad Política de Cookies Cláusulas legales RGPD
    © UNIR - Universidad Internacional de La Rioja
     
    Aviso Legal Política de Privacidad Política de Cookies Cláusulas legales RGPD
    © UNIR - Universidad Internacional de La Rioja